Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.
OpenAlex 토픽 ·
Cancer Immunotherapy and Biomarkers
Clostridium difficile and Clostridium perfringens research
Gut microbiota and health
APA
Yuntao Yao, Yifan Liu, et al. (2026). Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.. European urology. https://doi.org/10.1016/j.eururo.2026.04.003
MLA
Yuntao Yao, et al.. "Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.." European urology, 2026.
PMID
42034536
같은 제1저자의 인용 많은 논문 (5)
- Ionizable mesoporous silica nanoparticle-mediated siAURKB delivery for colorectal cancer therapy.
- The comparative diagnostic and therapeutic application value of FAPI PET/CT and F-FDG PET/CT in oncology.
- Integrated Single-Cell and Bulk Transcriptome Analysis Reveals the Prognostic Significance and Immune Regulatory Mechanisms of Sialylation in Hepatocellular Carcinoma.
- Microbiota in cancer: current understandings and future perspectives.
- Parthenolide and Its Derivatives in the Treatment of Respiratory Tract Diseases: Therapeutic Effects and Molecular Mechanisms.